These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 10498208)
1. Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore. Endo Y; Yoshimi T; Kimura K; Itai A Bioorg Med Chem Lett; 1999 Sep; 9(17):2561-4. PubMed ID: 10498208 [TBL] [Abstract][Full Text] [Related]
2. New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Endo Y; Yoshimi T; Yamakoshi Y Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):312-4. PubMed ID: 10705532 [TBL] [Abstract][Full Text] [Related]
3. Estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Endo Y; Yoshimi T; Iijima T; Yamakoshi Y Bioorg Med Chem Lett; 1999 Dec; 9(24):3387-92. PubMed ID: 10617077 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity study of estrogenic agonists bearing dicarba-closo-dodecaborane. Effect of geometry and separation distance of hydroxyl groups at the ends of molecules. Endo Y; Iijima T; Amakoshi Y; Kubo A; Itai A Bioorg Med Chem Lett; 1999 Dec; 9(23):3313-8. PubMed ID: 10612591 [TBL] [Abstract][Full Text] [Related]
5. Modulators of tumor necrosis factor alpha production bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Tsuji M; Koiso Y; Takahashi H; Hashimoto Y; Endo Y Biol Pharm Bull; 2000 Apr; 23(4):513-6. PubMed ID: 10784439 [TBL] [Abstract][Full Text] [Related]
7. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation. Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881 [TBL] [Abstract][Full Text] [Related]
8. Modulation of human neutrophil activity by adenosine modified with a carborane pharmacophore. Bednarska K; Olejniczak AB; Klink M; Sułowska Z; Leśnikowski ZJ Bioorg Med Chem Lett; 2014 Jul; 24(14):3073-8. PubMed ID: 24881569 [TBL] [Abstract][Full Text] [Related]
9. Role of the hydrophobic moiety of tumor promoters. Synthesis and activity of 2-alkylated benzolactams. Endo Y; Yokoyama A Bioorg Med Chem Lett; 2000 Jan; 10(1):63-6. PubMed ID: 10636245 [TBL] [Abstract][Full Text] [Related]
15. Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety. Ohta K; Iijima T; Kawachi E; Kagechika H; Endo Y Bioorg Med Chem Lett; 2004 Dec; 14(23):5913-8. PubMed ID: 15501068 [TBL] [Abstract][Full Text] [Related]
16. Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters. Endo Y; Iijima T; Yamakoshi Y; Fukasawa H; Miyaura C; Inada M; Kubo A; Itai A Chem Biol; 2001 Apr; 8(4):341-55. PubMed ID: 11325590 [TBL] [Abstract][Full Text] [Related]
17. Boron cluster-based development of potent nonsecosteroidal vitamin D receptor ligands: direct observation of hydrophobic interaction between protein surface and carborane. Fujii S; Masuno H; Taoda Y; Kano A; Wongmayura A; Nakabayashi M; Ito N; Shimizu M; Kawachi E; Hirano T; Endo Y; Tanatani A; Kagechika H J Am Chem Soc; 2011 Dec; 133(51):20933-41. PubMed ID: 22066785 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and DNA-binding properties of dinuclear platinum(II)-amine complexes of 1,7-dicarba-closo-dodecaborane(12). Woodhouse SL; Rendina LM Chem Commun (Camb); 2001 Dec; (23):2464-5. PubMed ID: 12240016 [TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of tetraol derivatives of 1,12-dicarba-closo-dodecaborane as non-secosteroidal vitamin D analogs. Fujii S; Kano A; Masuno H; Songkram C; Kawachi E; Hirano T; Tanatani A; Kagechika H Bioorg Med Chem Lett; 2014 Sep; 24(18):4515-4519. PubMed ID: 25149512 [TBL] [Abstract][Full Text] [Related]